Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$6.15
+0.1300 ( +2.16% ) 67.9K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$6.15
Previous close
$6.02
Volume
67.9K
Market cap
$345.48M
Day range
$5.89 - $6.22
52 week range
$1.62 - $7.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 18, 2023 |
4 | Insider transactions | 1 | Sep 18, 2023 |
10-q | Quarterly Reports | 61 | Aug 11, 2023 |
8-k | 8K-related | 14 | Aug 11, 2023 |
4 | Insider transactions | 1 | Jul 07, 2023 |
4 | Insider transactions | 1 | Jul 06, 2023 |